Treatment outcome of new smear positive patients of pulmonary tuberculosis treated under directly observed treatment, short-course in a rural tertiary care hospital of a hilly area

Authors

  • Aradhna Sharma Department of Pharmacology, Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India
  • Dinesh Kansal Department of Pharmacology, Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India
  • Kiran Katoch National JALMA Institute of leprosy and other mycobacterial diseases, Agra, Uttar Pradesh, India
  • Parveen Kumar Sharma Department of Pharmacology, Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India
  • Rekha Bansal Department of Pulmonary Medicine, Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India
  • Tarun Sharma Department of Medicine, Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20162558

Keywords:

Pulmonary tuberculosis, DOTS, Weight gain

Abstract

Background: Tuberculosis is one of the world’s most common causes of morbidity and mortality. The directly observed treatment, short-course (DOTS) Strategy aims to improve patient adherence to treatment and thereby prevents development of drug resistance.  Aims and Objectives: To study the treatment outcome in new smear positive patients of pulmonary tuberculosis treated under DOTS at DR. RPGMC Kangra at Tanda, H.P.

Methods: A prospective observational study was conducted over duration of seven months in Dr. RPGMC Kangra at Tanda, Himachal Pradesh, India. A total of 130 new smear positive (NSP) patients of pulmonary tuberculosis (PTB) were enrolled during study period after taking informed consent. Patients were started on category I and were followed till the completion of DOTS. Treatment outcomes were recorded as per RNTCP guidelines.

Results: Out of total 130 patients, 109 (83.8%) patients were cured, 14(10.7%) patients died, 2 (1.6%) patients treatment completed, 2(1.6%) patients defaulted, 2 (1.6%) patients were treatment failure and  in 1(0.7%) patient treatment regime was modified due to severe hypersensitivity reaction with HRZE. He was put on HES for one year. The mean weight ±SD was 44.5±3.53 kg at the time of start of treatment which increased to mean of 50.6±2.97 kg at the end of treatment. There was an average increase of 6.08±1.12 kg weight at the end of treatment. This was statistically significant and was evenly distributed in all age groups.

Conclusions: The high cure rate and less default rate ensures that the DOTS therapy is highly effective and safe and also the DOTS program is running successfully in this rural hilly area. The increase in weight at the end of treatment was found to be strongly associated with favourable treatment outcome (p<0.05). And also furthermore it may be concluded that increased weight can also be included as one of the criteria for the favourable treatment outcome.

References

Dubos R, Dubos J. The White Plague, Tuberculosis, Man and Society. London: Victor Gollancz; 1953.

Global Tuberculosis Control. World Health Organization Report; 2011. Available at: http://www.who.int/tb/publications/global_report.

Central TB Division, DGHS, Ministry of Health and Family Welfare, Government of India. RNTCP Annual Status Report, 2015. Available from URL: http://www.tbcindia.gov.in/index1.php?lang= 1& level=1&sublinkid=4160&lid=2807.

WHO/IUATLD.Global Project on Anti-tuberculosis Drug Resistance Surveillance, Anti-tuberculosis drug resistance in the World. Report No.4. Geneva, Switzerland.2012.

Esther SN, Godfrey SM, Eliud RW, Odd M. Delay in tuberculosis case detection in Pwani region, Tanzania: a cross sectional study. BMC Health Serv Res. 2009;9:196.

Mohamed GF, Jens HR, Tore WS, Randi SH, Gunnar B. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis. 2006;6:33.

Gupta SN, Gupta N, Gupta S. Surveillance data analysis of revised national tuberculosis control program of Kangra, Himachal Pradesh. J Fam Med Primary Care. 2013;2:250-5.

Global Tuberculosis control, Surveillance, Planning and Financing, WHO: Report 2004. Available at: http://www.who.int/tb/publications/global_report/2004/contents.pdf.

Sharma SK, Mohan A. Multidrug resistant tuberculosis. Indian J Med Res. 2004;120:354-76.

Khatri GR, Freidan TR. The status and prospects of tuberculosis control in India. Int J Tuberc lung Dis. 2000;43:193-200.

Govt. of India. TB India 2012, RNTCP Status Report, Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi.2012.

Govt. of India. 2005. DOTS Guidelines. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi.

Ahmed J, Chadha V K, Singh S, Venkatachalappa B, Kumar P. Utilization ofRNTCP services in rural areas of Bellary district, Karnataka, by gender, age and distance from health centre. Indian j tuberc 2009;56:62-8.

Mishra A, Mishra S,chouksy M, GautumP,Verma P, Srivastava D, Bansal M, gaur N, Patne S. A study of effectiveness of DOTS on Tuberculosis patients treated under RNTCP Program. NTI bulletin. 2007;43:47-50.

Gaikwad A,Deopujari K. A study of clinical profile and treatment outcome of DOTS regime in 250 Pulmonary and extra pulmonary tubercular patients in Hamida hospital, Bhopal, 2011. Chest. 2012;142:288-9.

Downloads

Published

2017-01-05

How to Cite

Sharma, A., Kansal, D., Katoch, K., Sharma, P. K., Bansal, R., & Sharma, T. (2017). Treatment outcome of new smear positive patients of pulmonary tuberculosis treated under directly observed treatment, short-course in a rural tertiary care hospital of a hilly area. International Journal Of Community Medicine And Public Health, 3(8), 2129–2132. https://doi.org/10.18203/2394-6040.ijcmph20162558

Issue

Section

Original Research Articles